Evidence map›Paper›PMID 35456328›Full record

ArticleJournal of clinical medicine2022

Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients.

Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) levels following erector spinae plane block (ESPB) in posterior lumbar decompression: a randomized, controlled trial.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2023
    Trial
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Matteo RegoloDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Mauro VaccaroDepartment of Emergency Medicine, San Marco-Polyclinic Academic Hospital, 95124 Catania, Italy.
Alessandra SorceDepartment of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro" (PROMISE), Unit of Nephrology and Hypertension, European Society of Hypertension Excellence Centre, University of Palermo, 90133 Palermo, Italy.ORCID 0000-0002-5267-3616
Benedetta StancanelliAcademic Unit of Internal Medicine, Cannizzaro Hospital, 95100 Catania, Italy.
Michele ColaciDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-3606-3404
Giuseppe NatoliAcademic Unit of Internal Medicine, Cannizzaro Hospital, 95100 Catania, Italy.
Mario RussoAcademic Unit of Internal Medicine, Cannizzaro Hospital, 95100 Catania, Italy.
Innocenza AlessandriaDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Massimo MottaDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Nicola SantangeloAcademic Unit of Internal Medicine, Cannizzaro Hospital, 95100 Catania, Italy.
Letizia FioritoDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-6162-7275
Ornella GiarrussoDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Federica GiangrecoDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Andrea ArenaAcademic Unit of Internal Medicine, Cannizzaro Hospital, 95100 Catania, Italy.
Paola NotoDepartment of Emergency Medicine, San Marco-Polyclinic Academic Hospital, 95124 Catania, Italy.
Claudio CiampiDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-1285-8464
Giuseppe CarpinteriDepartment of Emergency Medicine, San Marco-Polyclinic Academic Hospital, 95124 Catania, Italy.ORCID 0000-0001-9280-9621
Lorenzo MalatinoDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0003-2944-2729
University of Catania · ITOspedale Cannizzaro · ITEuropean Society of Hypertension · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory marker predicting the prognosis of several diseases. We aimed to assess its role as a predictor of mortality or admission to the intensive care unit in COVID-19 patients. We retrospectively evaluated a cohort of 411 patients with COVID-19 infection. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and C-reactive protein (CRP) of patients with COVID-19 were compared. The median age of our sample was 72 years (interquartile range: 70−75); 237 were males. Hypertension, diabetes and ischemic heart disease were the most common comorbidities. The study population was subdivided into three groups according to NLR tertiles. Third-tertile patients were older, showing significantly higher levels of inflammatory markers; 133 patients (32%) died during hospitalization, 81 of whom belonged to the third tertile; 79 patients (19%) were admitted to ICU. NLR showed the largest area under the curve (0.772), with the highest specificity (71.9%) and sensitivity (72.9%), whereas CRP showed lower sensitivity (60.2%) but slightly higher specificity (72.3%). Comparisons between NLR and CRP ROC curves were significantly different (p = 0.0173). Cox regression models showed that the association between NLR and death was not weakened after adjustment for confounders. Comparisons of ROC curves showed no significant differences between NLR, PLR, and CRP. Cox regression analysis showed that NLR predicted the risk of admission to ICU independently of demographic characteristics and comorbidities (HR: 3.9597, p < 0.0001). These findings provide evidence that NLR is an independent predictor of mortality and a worse outcome in COVID-19 patients and may help identify high-risk individuals with COVID-19 infection at admission.

Indexed as

CRPICUinflammationintensive care unitmortalityneutrophil-to-lymphocyte ratioNLRPLRprognostic biomarkersSARS-CoV2

Identifiers

PMID35456328
PMCPMC9027549
OpenAlexW4224073853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.